Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
48.06
-0.24 (-0.50%)
Nov 20, 2026, 2:08 PM EST - Market open
Travere Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $68 | Buy | Maintains | $68 | +41.49% | Nov 16, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $90 → $86 | Buy | Maintains | $90 → $86 | +78.94% | Nov 6, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Maintains $78 → $67 | Buy | Maintains | $78 → $67 | +39.41% | Nov 5, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $89 → $78 | Buy | Reiterates | $89 → $78 | +62.30% | Nov 4, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $70 → $72 | Buy | Maintains | $70 → $72 | +49.81% | Nov 4, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $71 → $70 | Buy | Reiterates | $71 → $70 | +45.65% | Nov 3, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $62 | Hold | Maintains | $62 | +29.01% | Nov 3, 2026 |
| Wedbush | Wedbush | Buy Maintains $76 | Buy | Maintains | $76 | +58.14% | Nov 3, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.